SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Gilead Science (GILD) Followers
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
961 87 0 GILD
Emcee:  SybilNicolas Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
236 Thanks Betty It IS A Good Article!! May POP GILD!! Who Knows these days?? BobBob Biersack-3/26/1997
235 The Mar. 31 "Fortune" has an article on biotechs. Gilead is favorablStarlight-3/25/1997
234 Chris all Bio-tech were taken down this week. Believe this is a sector thing. ABob Biersack-3/21/1997
233 Nothing like a drop of 5 or 6 points to get everyone's attention.<g> Starlight-3/21/1997
232 Today and yesterday look more like FIRE SALES than drills. What the heck is goSkywatcher-3/21/1997
231 Well, Elizabeth at least this thread is not too crowded, Did we have a "fiBob Biersack-3/21/1997
230 GILEAD NOW HAS A WEBSITE - gilead.com Check it out - it looks nice!Starlight-3/18/1997
229 Miles, Your listing is insightful, but is it fair to compare biotech "roowsnob-3/15/1997
228 chris, I heard this on CBS Radio national news last nite. I assume that'sjay silberman-3/12/1997
227 News regarding the flu/influenza drug Tuesday March 11 7:30 AM EDT Hoffmann-LaSkywatcher-3/11/1997
226 Miles, thanks for sharing that with us. Any chance you could run that for the David D. Long-2/28/1997
225 That's exactly the sort of question that we all should be asking. When cscaram(o)uche-2/27/1997
224 Rick, I can't help thinking about your noting that AGPH and GILD market capMiles Rhyne Hoffman, CFA-2/27/1997
223 Some companies have reached a market cap that can't be supported by near-tescaram(o)uche-2/27/1997
222 Chris <<<hang on to this one>>> I Agree!! Hang on to race alBob Biersack-2/27/1997
221 Not dead, just watching the MMs have a field day on this one. Every hour seems Skywatcher-2/27/1997
220 **WOW this is the silent thread, every one dead???***Bob Biersack-2/27/1997
219 Yup. Biota has a nice molecule. It's very high affinity, but the oral bioscaram(o)uche-2/23/1997
218 Rick, Ever hear of this company? If so, what's your opinion? Thanks. tejay silberman-2/23/1997
217 Cost recovery and "market need" largely determine pricing, rather thascaram(o)uche-2/19/1997
216 To: +Marshall (11513 ) From: +Bob Biersack Bob Biersack-2/19/1997
215 Thanks for posting the article for me. I wonder if anyone has a comment on the Skywatcher-2/18/1997
214 Tuesday February 18 9:18 AM EDT - Researchers Publish Pivotal efficacy Data FrMiles Rhyne Hoffman, CFA-2/18/1997
213 Chris, good info. what is your source?GENE DAVID HART-2/18/1997
212 Excellent results from Phase II/III trials with VISTIDE. Retinitis was substantSkywatcher-2/18/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News